Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Korosho to Take Measures to Improve Quality of Medical Services
October 28, 2002
- MEDICAL DEVICE NEWS IN BRIEF
October 28, 2002
- Review Fees to Be Hiked in April 2004
October 28, 2002
- DIAGNOSTIC NEWS IN BRIEF
October 28, 2002
- Council Recommends Strategic Approaches toward IP
October 28, 2002
- WORLD NEWS IN BRIEF
October 28, 2002
- 3 Active Ingredients Including Flunase Nasal Solution Approved
October 28, 2002
- Sankyo Acquires Cider Sante's Subsidiary of France
October 28, 2002
- REGULATORY NEWS IN BRIEF -1-
October 28, 2002
- REGULATORY NEWS IN BRIEF -2-
October 28, 2002
- WMA General Assembly Washington 2002
October 28, 2002
- Profit-Making Companies to Not Be Allowed to Operate Medical Facilities
October 28, 2002
- ED Awareness Campaign Successful: Pfizer
October 28, 2002
- JMA Strongly Opposed Operation of Hospitals by Profit-making Corporations
October 28, 2002
- BULLETIN
October 28, 2002
- Most Deregulations Proposed by Korosho Approved
October 28, 2002
- Asahi Kasei to Pursue "Selection and Concentration" Policy
October 28, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
October 28, 2002
- Sumitomo Chemical, Takeda to Establish New Agrochemical JV
October 28, 2002
- Ingredients in Ashitaba Effective for Osteoporosis: Takara Bio
October 28, 2002
ページ
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…